Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge

被引:182
|
作者
Koyasu, Sho [1 ,2 ]
Kobayashi, Minoru [1 ]
Goto, Yoko [3 ]
Hiraoka, Masahiro [3 ]
Harada, Hiroshi [1 ,4 ]
机构
[1] Kyoto Univ, Lab Canc Cell Biol, Dept Genome Dynam, Ctr Radiat Biol, Kyoto, Japan
[2] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan
[3] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan
[4] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol, Saitama, Japan
来源
CANCER SCIENCE | 2018年 / 109卷 / 03期
基金
日本科学技术振兴机构;
关键词
gene expression; hypoxia-inducible factor 1 (HIF-1); molecular mechanism; tumor hypoxia; TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTIONAL ACTIVITY; CANCER-THERAPY; FACTOR; 1-ALPHA; HIF-ALPHA; FACTOR-I; STABILIZES HIF-1-ALPHA; PROLYL; 4-HYDROXYLASES; ERYTHROPOIETIN GENE; BREAST-CANCER;
D O I
10.1111/cas.13483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator of various genes related to cellular adaptive responses to hypoxia. Dysfunctions in the regulatory systems of HIF-1 activity have been implicated in the pathogenesis of various diseases including malignant tumors and, thus, elucidating the molecular mechanisms underlying the activation of HIF-1 is eagerly desired for the development of novel anti-cancer strategies. The importance of oxygen-dependent and ubiquitin-mediated proteolysis of the regulatory subunit of HIF-1 (HIF-1) was first reported in 1997. Since then, accumulating evidence has shown that HIF-1 may become stable and active even under normoxic conditions; for example, when disease-associated genetic and functional alterations in some genes trigger the aberrant activation of HIF-1 regardless of oxygen conditions. We herein review the last two decades of knowledge, since 1997, on the regulatory mechanisms of HIF-1 activity from conventional oxygen- and proteolysis-dependent mechanisms to up-to-the-minute information on cancer-associated genetic and functional alteration-mediated mechanisms.
引用
收藏
页码:560 / 571
页数:12
相关论文
共 50 条
  • [21] iNOS Expression inhibits hypoxia-inducible factor-1 activity
    Yin, JH
    Yang, DI
    Ku, G
    Hsu, CY
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (01) : 30 - 34
  • [22] Copper manipulation of the transcriptional activity of hypoxia-inducible factor-1
    Zhang, Wenjing
    Wu, Zhijuan
    Liu, Xiaojuan
    Li, Pengfei
    Fu, Haiying
    Kang, Y. James
    FASEB JOURNAL, 2016, 30
  • [23] Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1α
    Koh, Mei Y.
    Spivak-Kroizman, Taly
    Venturini, Sara
    Welsh, Sarah
    Williams, Ryan R.
    Kirkpatrick, D. Lynn
    Powis, Garth
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (01) : 90 - 100
  • [24] Rac1 activity is required for the activation of hypoxia-inducible factor 1
    Hirota, K
    Semenza, GL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) : 21166 - 21172
  • [25] Regulation of Vascularization by Hypoxia-Inducible Factor 1
    Semenza, Gregg L.
    HYPOXIA AND CONSEQUENCES FROM MOLECULE TO MALADY, 2009, 1177 : 2 - 8
  • [26] Hypoxia-inducible factor 1 in autoimmune diseases
    Deng, Wei
    Feng, Xuebing
    Li, Xia
    Wang, Dandan
    Sun, Lingyun
    CELLULAR IMMUNOLOGY, 2016, 303 : 7 - 15
  • [27] Hypoxia-Inducible Factor 1 and Cardiovascular Disease
    Semenza, Gregg L.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 76, 2014, 76 : 39 - 56
  • [28] Hypoxia-inducible factor 1α in oral cancer
    Brennan, PA
    Mackenzie, N
    Quintero, M
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (07) : 385 - 389
  • [29] Hypoxia-inducible factor 1 and cancer pathogenesis
    Semenza, Gregg L.
    IUBMB LIFE, 2008, 60 (09) : 591 - 597
  • [30] The role of hypoxia-inducible factor 1 in atherosclerosis
    Gao, Linggen
    Chen, Qian
    Zhou, Xianliang
    Fan, Li
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (10) : 872 - 876